Archive for November, 2008

M2 Presswire - Biovail Corp and Wellbutrin In Review.

Wednesday, November 26th, 2008

M2 PRESSWIRE-17 January 2007-Pinnacle Digest: Biovail Corp and Wellbutrin In Review(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:17012007 Biovail Corporation (NYSE:BVF) (TSX:BVF) experienced a gain of 2.29 Tuesday accompanied by 421,066 shares trading hands. Their marketing partner GlaxoSmithKline is on the move and recently announced that that Wellbutrin XR(R)(1) (bupropion hydrochloride modified-re…

Independent, The (London) - Eon says generic Wellbutrin sales to be delayed

Sunday, November 23rd, 2008

EON LABS, a US pharmaceuticals group, yesterday said its introduction of a generic version of the GlaxoSmithKline antidepressant Wellbutrin was being delayed after GSK won a temporary restraining order. A judge entered an order that prevents Eon from selling 100mg tablets of its generic Wellbutrin, chemica…

Clusters of Genetic Variants Linked to Distinct Treatment Responses for Smoking Cessation

Wednesday, November 19th, 2008

Clusters of Genetic Variants Linked
to Distinct Treatment Responses for Smoking Cessation
Findings May Help to Match Smokers with Treatments Most Likely
to He…

Internal Medicine News - Wellbutrin XL.(NEW & APPROVED)(Brief article)

Saturday, November 15th, 2008

Wellbutrin XL

(bupropion extended release, GlaxoSmithKline)

An antidepressant for preventing seasonal major depressive episodes in people with seasonal affective disorder (SAD). The first drug approved for a SAD-related indication. Previously approved for major depressive disorder and smoking cessation.

* Recommended Dosage: Start at 150 mg/day; if tolerated, increase to 300 mg/day after 1 week. In studies, treatment continued through the winte…

Business Wire - Biovail Reports Second-Quarter 2007 Financial Results

Tuesday, November 11th, 2008

Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression, N Engl J Med 2007; 356:1711-1722.
* Clinical question
Is the addition of an antidepressant to a mood stabilizer an effective strategy for short-term treatment of major depressive episodes in patients …

High anxiety is no laughing matter-Print

Sunday, November 9th, 2008

A 1977 film by film-maker Mel Brooks entitled, High Anxiety takes a comedic look at the mental health industry and the various approaches taken to treat anxiety disorder. The movie was given two Golden Globe nominations even if it did not do too well at the box office. Brooks, known throughout Hollywood as a comedic genius, deliberately made this movie…

A Drug to Help you Stop Smoking

Thursday, November 6th, 2008

The Online Clinic is pleased to announce that it is now able to prescribe Champix for patients who want to give up smoking. Champix was launched by Pfizer earlier this year following two identical double blind trials which demonstrated the drugs safety and efficacy.

Champix …

Journal of Family Practice - Bupropion plus nicotine replacement no better than replacement alone

Monday, November 3rd, 2008

Business Editors/Legal, Health & Medical Writers
HAYWARD, Calif.–(BW HealthWire)–Oct. 10, 2000
IMPAX Laboratories Inc. (NASDAQ NM: IPXL) today announced that Glaxo Wellcome, Inc., a wholly owned subsidiary of Glaxo Wellcome, plc (NYSE: GLX), has filed a lawsuit against the Company in the Northern District of California alleging patent infringement related to IMPAX’s filing of Abbreviated New Drug Applications (ANDA) for generic versions of Wellbutrin SR(R) (bupropion …

News: Teva Pharmaceuticals USA Responds to FDA Findings on …

Saturday, November 1st, 2008

Teva Pharmaceuticals USA issues the following statement in
response to the “Review of Therapeutic Equivalence Generic Bupropion
XL 300 mg and Wellbutrin XL 300 mg” released by FDA on April 16, 2008:
As the largest generic drug company in the world, Teva’s first
priority is to ensure that patients receive products with
unquestioned safety and effectiveness. Teva Pharmaceutical